Literature DB >> 2990706

Therapeutic approaches to patients with AIDS.

H C Lane, H Masur, E P Gelmann, A S Fauci.   

Abstract

The immune systems of patients with acquired immunodeficiency syndrome are characterized by a profound defect in the number and function of helper/inducer T-lymphocytes, particularly at the level of soluble antigen recognition. Due to this selective yet profound defect in the immune system, these patients are prone to recurrent severe opportunistic infections and Kaposi's sarcoma. While therapies exist for some of these complications of acquired immunodeficiency syndrome, no effective therapies exist for the underlying immune defect of this syndrome. Reviewed here are some of our recent attempts at immune reconstitution in acquired immunodeficiency syndrome, using either whole scale immune reconstitution through the use of lymphocyte transfers and bone marrow transplantation or enhancement of the remaining immune systems with the T-cell-derived lymphokines interleukin-2 or immune gamma-interferon. In addition, recent advances in the therapy of Pneumocystis carinii pneumonia and disseminated cytomegalovirus disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990706

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  Immune reconstitution of acquired immune deficiency syndrome.

Authors:  Jie Wang; Hong-sheng Lin; Meng-yu Liu; Yong Li
Journal:  Chin J Integr Med       Date:  2010-11-26       Impact factor: 1.978

2.  Viral infections in the acquired immunodeficiency syndrome.

Authors:  S E Miller; D N Howell
Journal:  J Electron Microsc Tech       Date:  1988-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.